Skip to content

Diagnostic value of OCTA in diabetic nephropathy

Diagnostic value of OCTA in diabetic nephropathy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047268
Enrollment
Unknown
Registered
2021-06-11
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

T2DM group vs healthy control group:None

Sponsors

The Seventh Affiliate Hospital of Sun Yan-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria of normal control group were as follows : 1. Subjects with education level of primary school or above; 2. Subjects with corrected visual acuity >= 4.9 (standard logarithmic visual acuity chart); 3. Subjects with diopter less than or equal to ± 3.0d; 4. Subjects with IOP = 4.6 (standard logarithmic visual acuity chart); 5. Subjects with diopter less than or equal to ± 3.0d; 6. Subjects with IOP <= 21mmhg (1mmhg = 0.133kpa) denied history of ocular hypertension; 7. Subjects with no previous history of intraocular surgery, laser and trauma; 8. No obvious abnormality of anterior segment was found in slit lamp examination.

Exclusion criteria

Exclusion criteria: 1. Acute complications of diabetes mellitus; 2. Severe chronic complications; 3. Identify inflammatory diseases; 4. Autoimmune diseases; 5. History of tumor; 6. History of hereditary cerebrovascular disease; 7. Alzheimer's disease related dementia; 8. History of head trauma or stroke and other neurological diseases; 9. Vitamin B deficiency; 10. History of thyroid dysfunction; 11. History of exposure to poisons; (Note: points 9-11 mainly affect peripheral neuropathy, but have little effect on cerebral small vessel disease); 12. Diseases with obvious refractive medium turbidity affecting fundus examination and inability to fix vision; 13. Other fundus diseases other than diabetic retinopathy, such as glaucoma (which has been excluded in the inclusion criteria), age-related macular degeneration, high myopia (which has been excluded in the inclusion criteria); 14. Hypertensive retinopathy; 15. Ischemic optic neuropathy; 16. Central serous chorioretinopathy and other retinopathy that may interfere with OCT analysis.

Design outcomes

Primary

MeasureTime frame
vessel density;

Countries

China

Contacts

Public ContactLin Xiahong

The Seventh Affiliate Hospital of Sun Yan-Sen University

2413368792@qq.com+86 18965732072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026